# Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers

> **NCT06999590** · PHASE4 · RECRUITING · sponsor: **Tiger Biosciences, LLC.** · enrollment: 500 (estimated)

## Conditions studied

- Pressure Ulcer
- Ulcer
- Ulcer, Pressure
- Pressure Injury

## Interventions

- **OTHER:** ACApatch™
- **OTHER:** caregraFT™
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT06999590
- **Lead sponsor:** Tiger Biosciences, LLC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-20
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-06-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06999590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06999590, "Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06999590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*